NCT07679022

Brief Summary

This randomized controlled trial will evaluate whether a brief preoperative virtual reality intervention reduces anxiety and improves early recovery in adults undergoing elective gynecological surgery. Approximately 140 participants will be randomly assigned in a 1:1 ratio to either virtual reality in addition to usual care or usual care alone. The virtual reality intervention will consist of approximately 10-20 minutes of an immersive relaxation experience before surgery. The primary outcome is the change in preoperative anxiety measured before and after the intervention. Secondary outcomes include postoperative quality of recovery, pain, opioid consumption, postoperative nausea and vomiting, and early recovery-related healthcare outcomes.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
29mo left

Started Sep 2026

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 25, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 1, 2026

Completed
3 months until next milestone

Study Start

First participant enrolled

September 30, 2026

Expected
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2028

2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2029

Last Updated

July 1, 2026

Status Verified

June 1, 2026

Enrollment Period

2.3 years

First QC Date

June 25, 2026

Last Update Submit

June 25, 2026

Conditions

Keywords

Virtual RealityPerioperative CareGynecologic SurgeryQuality of RecoveryQoR-15Preoperative AnxietyPostoperative PainOpioid ConsumptionPostoperative Nausea and VomitingNonpharmacologic Intervention

Outcome Measures

Primary Outcomes (1)

  • Quality of Postoperative Recovery Measured With QoR-15

    Postoperative recovery will be assessed using the 15-item Quality of Recovery questionnaire (QoR-15). The total score ranges from 0 to 150, with higher scores indicating better quality of recovery.

    24 hours after surgery

Secondary Outcomes (8)

  • Change in Preoperative Anxiety

    From immediately before to immediately after the intervention, approximately 10-20 minutes

  • Postoperative Pain Intensity

    Up to 72 hours after surgery

  • Postoperative Opioid Consumption

    During the first 24 hours after surgery

  • Incidence of Postoperative Nausea and Vomiting

    During the first 24 hours after surgery

  • Duration of Stay in the Post-Anesthesia Care Unit

    On the day of surgery

  • +3 more secondary outcomes

Study Arms (2)

Virtual Reality Plus Usual Care

EXPERIMENTAL

Participants receive a preoperative virtual reality session in addition to usual perioperative care. The session lasts approximately 10-20 minutes and is delivered in the waiting or preoperative area using calm nature or relaxation scenes intended to promote comfort and distraction.

Behavioral: Preoperative Virtual Reality

Usual Care

ACTIVE COMPARATOR

Participants receive usual perioperative care without virtual reality during the corresponding preoperative period.

Other: Usual Perioperative Care

Interventions

A single preoperative virtual reality session lasting approximately 10-20 minutes, administered in the waiting or preoperative area. Participants view calm nature, relaxation, or guided-breathing scenes using a virtual reality headset. The intervention is intended to provide relaxation, comfort, and distraction before surgery.

Virtual Reality Plus Usual Care

Participants receive standard perioperative care according to local clinical routines. No preoperative virtual reality session is provided during the corresponding intervention period.

Usual Care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 18 years or older.
  • Scheduled to undergo elective gynecological surgery according to the study protocol at a participating center where virtual reality can be provided.
  • Able and willing to provide informed consent for study participation, 1:1 randomization, and use of virtual reality.

You may not qualify if:

  • Increased risk of adverse effects related to virtual reality, including pronounced motion sickness, claustrophobia, or photosensitive epilepsy.
  • Active substance use disorder or active misuse of alcohol or illicit drugs.
  • Severe chronic pain and/or regular preoperative opioid treatment, as defined in the study protocol.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pain, PostoperativePostoperative Nausea and Vomiting

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsNauseaSigns and Symptoms, DigestiveVomiting

Central Study Contacts

Pether Jildenstål, Professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Open-label study because participants and clinical staff are aware of whether the preoperative virtual reality intervention is administered.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Two-arm, parallel-group randomized controlled trial with participants allocated in a 1:1 ratio to preoperative virtual reality plus usual care or usual care alone.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 25, 2026

First Posted

July 1, 2026

Study Start (Estimated)

September 30, 2026

Primary Completion (Estimated)

December 31, 2028

Study Completion (Estimated)

February 28, 2029

Last Updated

July 1, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared because the dataset contains sensitive health information. Due to privacy and confidentiality concerns, and in accordance with ethical approval and applicable data protection regulations (GDPR), individual-level data cannot be made publicly available.